Boc-Val-Cit-OH

Boc-Val-Cit-OH, also known as tert-Butyloxycarbonyl-L-valyl-L-citrulline, is a synthetic dipeptide derivative widely utilized in peptide chemistry and biochemical research. Structurally, it features a Boc-protected N-terminus, combining the amino acids valine and citrulline in a linear sequence. This compound is particularly significant in the development of peptide-based conjugates and prodrugs, offering a valuable tool for researchers engaged in the synthesis and functional modification of peptides. Its unique combination of a branched-chain amino acid and a non-proteinogenic residue provides versatility in the design of peptide linkers and substrates for enzymatic studies.

Peptide Synthesis: Boc-Val-Cit-OH serves as a critical building block in solid-phase peptide synthesis (SPPS) and solution-phase methods, enabling the assembly of custom peptide sequences. The presence of the Boc protecting group facilitates selective deprotection and coupling reactions, allowing for precise incorporation into growing peptide chains. Its use is especially advantageous when constructing peptides that require orthogonal protection strategies or when introducing specific dipeptide motifs for downstream functionalization.

Antibody-Drug Conjugate (ADC) Linker Research: In the field of targeted drug delivery, Boc-Val-Cit-OH is frequently employed as a precursor for the synthesis of cleavable peptide linkers. The valine-citrulline dipeptide motif is recognized for its susceptibility to cathepsin B-mediated cleavage, making it a preferred choice in the design of linkers for antibody-drug conjugates. Researchers utilize this compound to develop linkers that remain stable in systemic circulation but are selectively cleaved within the lysosomal environment of target cells, enabling controlled payload release.

Enzymatic Substrate Development: The dipeptide structure of Boc-Val-Cit-OH makes it a valuable substrate or intermediate in studies investigating protease specificity and activity, particularly for cathepsin family enzymes. By incorporating this motif into larger peptide substrates or reporter constructs, scientists can probe the kinetics and substrate preferences of proteolytic enzymes, advancing understanding of protease function in physiological and pathological processes.

Prodrug and Bioconjugation Strategies: Due to its well-characterized cleavage properties and chemical stability, Boc-Val-Cit-OH is often incorporated into prodrug systems and bioconjugates. Its role as a linker allows for the attachment of therapeutic agents, imaging probes, or other functional molecules to carrier systems, with release triggered by enzymatic cleavage. This application supports the development of advanced delivery systems in preclinical research, facilitating site-specific activation and improved selectivity.

Peptide Functionalization and Modification: The compound's dual amino acid composition and protected N-terminus offer flexibility for further chemical modification. Researchers leverage Boc-Val-Cit-OH to introduce functional groups, labeling moieties, or other modifications at defined positions within peptide sequences. This capability is essential in the creation of tailored peptide probes, affinity tags, or specialized biomolecular tools for diverse biochemical and analytical applications.

1. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

2. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

3. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

4. Emu oil in combination with other active ingredients for treating skin imperfections

5. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef